Vascular Web Logo

SVS  SVS Foundation
A A A
VascularWeb

 Wednesday, May 29

 

​ ​

All events take place at the Moscone West Convention Center unless otherwise noted.

​6:00 am - 6:30 pm Vascular Annual Meeting Registration Open​ - Level 1 Lobby
​6:00 am - 7:00 am

Postgraduate Courses Breakfast ​- Level 3 Lobby

7:00 am - 5:00 pm​

​POSTGRADUATE COURSES (Separate registration fee required)

7:00 am – 10:00 am
P1: Hemodialysis Access – Current Challenges - Room 3014/16

At the end of this session, participants should be able to:
  1. Discuss the national data on fistula creation and use.
  2. Develop an approach to the non-maturing dialysis fistula.
  3. Identify options for dialysis access in the pediatric population.
  4. Explain the technique of lower extremity fistula creation.
  5. Develop an appreciation of non-thrombotic access complications.
Moderators: Mark R. Nehler MD, University of Colorado, Anschutz Medical Campus, Denver, CO
Ahmed M. Abou-Zamzam, Jr MD, Loma Linda University Medical Center, Loma Linda, CA
 
7:00 am 
Overview – Modern ESRD Population/Fistula First National Data
Mark R. Nehler MD, University of Colorado, Anschutz Medical Campus, Denver, CO
 
7:20 am
Failure to Mature – The Role of Surveillance and Intervention
Alik Farber MD, Boston University Medical Center, Boston University School of Medicine, Boston, MA
 
7:45 am
When Fistula-First Is Not Possible – Non-Autologous Dialysis Conduits
Mark R. Nehler MD, University of Colorado, Anschutz Medical Campus, Denver, CO
 
8:10 am
Non-thrombotic Complications of Dialysis Access
Linda M. Harris MD, State University of New York at Buffalo, Buffalo, NY
 
8:35 am
Pediatric Dialysis Access
Vincent L. Rowe MD, Keck Medical School, University of Southern California, Los Angeles, CA
 
9:00 am
The Use of Axillary Vessels in Difficult Dialysis Cases
Theodore H. Teruya MD, Jerry Pettis VA and Loma Linda University Medical Center, Loma Linda, CA
 
9:20 am
Lower Extremity Dialysis Autogenous Access
Ahmed M. Abou-Zamzam, Jr MD, Loma Linda University Medical Center, Loma Linda, CA
 
9:40 am
Panel Discussion
P2: Best Practices for Thoracic Outlet Syndrome - Room 3018/20 
 
At the end of this session, participants should be able to:
  1. Identify strategies for workup, treatment and follow-up of patients with thoracic outlet syndrome.
  2. Evaluate best algorithms for treatment of venous and neurogenic TOS.
  3. Develop methods for optimal surgical management of TOS.
  4. Describe alternate non-surgical methods of TOS therapy.
  5. Explain how to handle patients with recurrent TOS.
Moderators: Jason T. Lee MD, Stanford University Medical Center, Stanford, CA
Robert W. Thompson MD, Washington University School of Medicine, St. Louis, MO    

7:00 am
Introduction
 
7:05 am
History of Thoracic Outlet Syndromes
Herbert I. Machleder MD, UCLA Medical Center, Los Angeles, CA
 
7:15 am
The Scope of the Problem
Jason T. Lee MD, Stanford University Medical Center, Stanford, CA
 
7:20 am
The Case for Creating National Guidelines for TOS Therapies
Karl A. Illig MD, University of South Florida, Tampa, FL
 
7:30 am
Neurogenic TOS: Workup and Surgical Management
Hugh A. Gelabert MD, UCLA Medical Center, Los Angeles, CA
 
7:45 am
MRI for Diagnosis of nTOS
Scott Werden MD, Vanguard Specialty Imaging, San Francisco, CA
 
7:55 am
Physical Therapy for nTOS
Peter Edgelow PhD, Physiotherapy Associates, Hayward, CA
 
8:05 am
Highly Selective Algorithm for nTOS
Venita Chandra MD, Stanford University Medical Center, Stanford, CA
 
8:15 am
Don’t Forget About Pec Minor Syndrome
Richard J. Sanders MD, Denver, CO
 
8:25 am
Panel Discussion
 
8:35 am
Break
 
8:50 am
Venous TOS (Paget-Schroetter Syndrome): Workup, Early, and Definitive Management
Julie Ann Freischlag MD, Johns Hopkins University, Baltimore, MD
 
9:05 am
Conservative Management of vTOS
Kaj H. Johansen MD PhD FACS, Swedish Medical Center, Seattle, WA
 
9:15 am
Infraclavicular Approach for vTOS
Darren B. Schneider MD, Cornell-Weill School of Medicine, New York, NY
 
9:25 am
Venous Reconstructions during TOS Surgery
J. Ernesto Molina MD PhD, University of Minnesota, Minneapolis, MN
 
9:35 am
Reoperations for TOS
Robert W. Thompson MD, Washington University School of Medicine, St. Louis, MO
 
9:45 AM
Panel Discussion
​10:00 am - 10:15 am

​Coffee Break - Level 3 Foyer

10:15 am – 1:15 pm
P3: Technical Aspects of Complex Open Vascular Surgery -Room 3014/16    
At the end of this session, participants should be able to: 

  1. Describe the technical aspects of complex open aortic and thoracoabdominal aneurysm repair.
  2. Explain surgical techniques for EVAR explants.
  3. Identify the key features in the management of infected aortic grafts.
  4. Discuss technical points of aortic aneurysm repair among patients with connective tissue disorders.
  5. Describe the most common renal anomalies and the surgical techniques to deal with them during aortic or renal surgery.
  6. Explain the surgical approaches to both chronic and acute mesenteric ischemia.
  7. Describe the steps and technical points of obturator bypass.
  8. Explain the surgical technique for thoracofemoral bypass.
Moderators: Kellie R. Brown MD, The Medical College of Wisconsin, Milwaukee, WI
Mark K. Eskandari MD, Northwestern University Feinberg School of Medicine, Chicago, IL
 
10:15 am
Technical Aspects of AAA Repair (Retroperitoneal, Transperitoneal, Infrarenal, Suprarenal)
Kenneth J. Cherry MD, University of Virginia, Charlottesville, VA
 
10:30 am
Techniques for Open Thoracoabdominal Aortic Aneurysm Repair
Charles W. Acher MD, University of Wisconsin, Madison, WI
 
10:45 am
Techniques for EVAR Explants
Jonathan L. Eliason MD, University of Michigan, Ann Arbor, MI
 
11:00 am
Management of Infected Aortic Grafts
Dennis F. Bandyk MD FACS, University of California – San Diego School of  Medicine, La Jolla, CA
 
11:15 am
Techniques for AAA in the Setting of Connective Tissue Disorder
James H. Black MD, Johns Hopkins Medical Center, Baltimore, MD
 
11:30 am
Panel Discussion
 
11:45 am
Break
 
12:00 pm
Dealing with Anomalous Renal Vasculature
Jeffrey L. Ballard MD FACS, Vascular & Interventional Specialists of Orange County, St. Joseph Hospital, Orange, CA
 
12:15 pm
Techniques for Operative Treatment of Mesenteric Ischemia
Kellie Brown MD, Medical College of Wisconsin, Milwaukee, WI
 
12:30 pm
Techniques for Obturator Bypass
Joseph S. Giglia MD, University of Cincinnati, Cincinnati, OH
 
12:45 pm
Techniques for Thoracofemoral Bypass
Walter J. McCarthy MD, Rush University Medical Center, Chicago, IL
 
1:00 pm
Panel Discussion
 

P4: Carotid Repair 2013: Why, Who, When and How? - Room 3018/20

    At the end of this session, participants should be able to: 
  1. Compare the results of CAS and CEA and how they influence the choice of procedure.
  2. Propose metrics of quality and risk adjustment based on national benchmarks for carotid interventions.
  3. Describe ways to prevent CEA complications.
  4. Explain the rationale for stent and cerebral protection choice for CAS in individual clinical situations.
  5. Prescribe appropriate management for patients with asymptomatic carotid disease.
  6. Describe the indications and risks of urgent or emergent carotid intervention.
  7. Describe best practices in the choice and performance of carotid interventions.

Moderators: William J. Quinones-Baldrich MD, University of California, Los Angeles, CA
Peter A. Schneider MD, Kaiser Permanente Medical Group, Honolulu, HI

10:15 am
Introduction

10:20 am
Results of CEA and CAS: Have They Changed in the Last 10 Years?
Michael Caps MD, Kaiser Permanente Medical Group, Honolulu, HI

10:32 am
Quality Assessment: National Benchmarks for CAS and CEA
Jon S. Matsumura MD, University of Wisconsin School of Medicine and Public Health, Madison, WI

10:44 am
Most Complications of CEA Can Be Prevented
William J. Quinones-Baldrich MD, University of California, Los Angeles, CA

10:56 am
Video: Eversion Endarterectomy
Philip S. Paty MD, The Vascular Group, PLLC, Albany, NY

11:08 am
Choosing the Best Stent and Cerebral Protection for CAS
Darren B. Schneider MD, Weill Cornell Medical College, New York, NY

11:20 am
Video: How and When Is It Better to Use Reversed Flow Devices for Cerebral Protection during CAS?
Sean P. Lyden MD, The Cleveland Clinic Foundation, Cleveland, OH

11:32 am
Break

11:52 am
Optimal Medical Management for the Carotid Patient
Thomas F. Rehring MD, Colorado Permanente Medical Group, Denver, CO

12:04 pm
Proper Pre Intervention Work-Up for CEA and CAS
Rabih A. Chaer MD, University of Pittsburgh, Pittsburgh, PA

12:16 pm
Proper Selection of Asymptomatic Patients for Carotid Repair
Robert Hye MD, Kaiser Permanente San Diego Medical Center, San Diego, CA

12:28 pm
Urgent or Emergent Carotid Intervention
Wesley S. Moore MD, Division of Vascular Surgery, UCLA, Los Angeles, CA

12:40 pm
Technical Aspects of CAS: Best Practices for Minimizing Stroke
Firas F. Mussa MD, New York University, New York, NY

12:52 pm
Panel: Innovations and Future Trends That Will Make Carotid Repair Safer and Better

1:15 pm - 2:00 pm

​2:00 pm – 5:00 pm

Postgraduate Courses Lunch - Level 3 Foyer

P5: PVD: Endovascular Treatments of the Lower Extremity - Room 3014/16

At the end of this session, participants should be able to: 
  1. Explain how and when to use alternative lower extremity access.
  2. Compare differences between currently available closure devices.
  3. List multiple options for treating chronic total occlusions.
  4. Explain the outcomes for drug eluting stents and the potential role for drug eluting balloons.
  5. Explain the roles and outcomes of various therapies for tibial disease.
Moderators: Sean P. Lyden MD, The Cleveland Clinic Foundation, Cleveland, OH
Edward Y. Woo MD, Hospital of the University of Pennsylvania, Philadelphia, PA
 
2:00 pm
Alternative Access – Popliteal, Tibial, Pedal-How and When to Use Each
Michael J. Singh MD, UPMC Heart and Vascular Institute, Pittsburgh, PA
 
2:20 pm
Overview of Closure Devices – What’s Out There, are They Warranted and if so, When?
Ali Azizzadeh MD, University of Texas Medical School, Houston, TX
 
2:40 pm
Common Femoral Disease – Endorx Yes or No, Atherectomy or To Stent or Not to Stent
Benjamin M. Jackson MD, University of Pennsylvania, Philadelphia, PA
 
3:00 pm
Chronic Total Occlusions – Subintimal Recanalization is Best With or Without Reentry
Sharif Ellozy MD, The Mount Sinai Medical Center, New York, NY
 
3:20 pm
Chronic Total Occlusions – CTO Devices are Key What’s Out There and New
Neal S. Cayne MD, New York University Medical Center, New York, NY
 
3:40 pm
Drug Eluting Stents – Will It Change My Practice?
Andres Schanzer MD, University of Massachusetts Medical School, Worcester, MA
 
4:00 pm
Drug Eluting Balloons – What Is the Current Status?
Peter A. Schneider MD, Kaiser Permanente Medical Group, Honolulu, HI
 
4:20 pm
New Stent Technologies – Bioresorbable and Others
Timur P. Sarac MD, The Cleveland Clinic, Cleveland, OH
 
4:40 pm
BK Lesions – What’s the Best Strategy Now and in the Future?
Rabih A. Chaer MD, University of Pittsburgh, Pittsburgh, PA

P6: Critical Issues for Endovascular Repair of Complex Aortic Aneurysms - Room 3018/20
 
At the end of this session, participants should be able to: 
  1. Describe current and novel technological developments for endovascular incorporation of aortic side branches.
  2. Define anatomical measurements and review case planning strategies.
  3. Review outcomes of custom-made, off-the-shelf and physician-modified fenestrated and branched endografts.
  4. Review the FDA perspective and implications of use of stent-grafts for off-label indications and physician-modified designs.
Moderators: Gustavo Oderich MD, Mayo Clinic, Rochester, MN
Mark F. Fillinger MD Dartmouth-Hitchcock Medical Center, Lebanon, NH
 
2:00 pm
Fenestrated Endografts – Current Designs and What Is Coming on the Pipeline?
Mark A. Farber MD, University of North Carolina Hospitals, Chapel Hill, NC
 
2:15 pm
Selecting the Healthy Aorta to Plan Successful Fenestrated Repair for Pararenal Aneurysms
Tara M. Mastracci MD, The Cleveland Clinic, Cleveland, OH
 
2:30 pm
Tips and Tricks for Implantation of Fenestrated Endografts – How to Avoid and to Get Out of Trouble
Gustavo Oderich MD, Mayo Clinic, Rochester, MN
 
2:45 pm
Renal and Visceral Branches – Determinants of Patency and How to Optimize Results
Matthew J. Eagleton MD, The Cleveland Clinic, Cleveland, OH
 
3:00 pm
Preliminary Results of Novel Off-The-Shelf Design with Movable Fenestrations
Peter R. Nelson MD, University of Florida College of Medicine, Gainesville, FL
 
3:15 pm
Preliminary Results of Novel Off-The-Shelf Design with P-Branch Fenestrations
Timothy A. Resch MD, Skane University Hospital, Malmo, Sweden
 
3:30 pm
Break
 
3:45 pm
Surgeon-Modified Branched-Fenestrated Repairs: Are They a Viable Option?
Mark F. Fillinger MD Dartmouth-Hitchcock Medical Center, Lebanon, NH
 
4:00 pm
Chimneys: Do Results Justify Their Use?
David J. Minion MD, University of Kentucky College of Medicine, Lexington, KY
 
4:15 pm
Planning Branched-Fenestrated Cases
Matthew P. Sweet MD, University of Washington Medical Center, Seattle, WA
 
4:30 pm
Complications of Chimney and Surgeon-Modified Grafts and How to Avoid Them
Adam W. Beck MD, University of Florida, Gainesville, FL
 
4:45 pm
What Does the FDA Want You to Know About Chimneys and Surgeon-Modified Endografts
Dorothy B. Abel, BSBME, Food and Drug Administration, Rockville, MD
 
9:30 am - 12:30 pm​

V1: Peripheral Vascular Surgery Society Paper Session I - Room 3022/24

At the end of this session, participants should be able to: 

  1. Discuss recent developments with respect to diagnostic imaging and percutaneous therapies for carotid, thoracic, renal and lower extremity vasculature.
  2. Describe expected outcomes following open and endovascular techniques used to treat thoracic aortic aneurysms, carotid stenosis and peripheral arterial disease in a contemporary setting.
  3. Apply up-to-date results in day-to-day practice to maximize success with contemporary open and endovascular techniques across various vascular territories.
  4. Discuss recent developments within the field of hemodynamic stabilization via endovascular techniques in combat environments.
Moderators: Jonathan L. Eliason MD, University of Michigan, Ann Arbor, MI
Matthew A. Corriere MD MS, Wake Forest University School of Medicine, Winston-Salem, NC
 
9:30 am
PVSS1. Open Surgical Techniques for Repair of Type 3 and 4 Thoracoabdominal Aortic Aneurysms: Is One Better Than the Others?
Muhammad Ali A. Rana, Peter Gloviczki, Harbuzariu Catalin, Audra Duncan, Manju Kalra, Gustavo S. Oderich, Mark D. Fleming, Thomas C. Bower
Vascular and Endovascular Surgery, Mayo Clinic, Rochester, MN.
 
NORMAN M. RICH AWARD
 
9:44 am
PVSS2. Pharmacologic Attenuation of the Hyperdynamic Response after Aortic Occlusion
Wayne Causey, Seth Miller, Matthew Martin, Niten Singh 
Madigan Hospital, Tacoma, WA.
 
William P. Robinson, Rupal Patel, Jesse Columbo, Francesco A. Aiello, Andres Schanzer, Donald T. Baril, Elias J. Arous, Louis M. Messina
Division of Vascular and Endovascular Surgery, University of Massachusetts Medical School, Worcester, MA.
 
Joseph Sidaoui, Theodore H. Yuo, Luke K. Marone, Larry Fish, Michel Makaroun, Rabih Chaer
Surgery, UPMC, Pittsburgh, PA.
Patrick Geraghty1, Thomas E. Brothers2, David L. Gillespie3, Gilbert R. Upchurch4, Michael C. Stoner5, Flora S. Siami6, Christopher T. Kenwood6, Philip P. Goodney7
1Washington University School of Medicine, St Louis, MO; 2Medical University of South Carolina, Charleston, SC; 3University of Rochester Medical Center, Rochester, NY; 4University of Virginia Medical School, Charlottesville, VA; 5East Carolina University, Greenville, NC; 6New England Research Institutes, Inc, Watertown, MA; 7Dartmouth-Hitchcock Medical Center, Lebanon, NH.
 
Jessica B. Wallaert, Jack L. Cronenwett, David H. Stone, Richard J. Powell, Brian Nolan, Randall R. DeMartino, Philip P. Goodney
Dartmouth Hitchcock Medical Center, Lebanon, NH.
 
Virendra I. Patel, Jeanwan Kang, Shankha Mukhopadhyay, Mark F. Conrad, David C. Brewster, Christopher J. Kwolek, Richard P. Cambria, Glenn M. LaMuraglia
Vascular and Endovascular Surgery, Massachusetts General Hospital, Boston, MA.
Panos Kougias1, Briauna Lowery1, Sherene Sharath1, Peter H. Lin2, Carlos Bechara1, George Pisimisis1, Taemee Pak2, Neal R. Barshes1
1Surgery, Michael E. DeBakey VAMC, Houston, TX; 2Baylor College of Medicine, Houston, TX.
Warren J. Gasper, Hugh Alley, Maria Aleshin, Joseph Rapp, Marlene Grenon, Michael S. Conte, Christopher D. Owens
Vascular Surgery, University of California San Francisco, San Francisco, CA.
 
Andrew J. Meltzer, Peter H. Connolly, Heather L. Gill, Douglas W. Jones, John K. Karwowski, Harry L. Bush, Darren B. Schneider
Vascular Surgery, Weill Cornell Medical College / New York-Presbyterian, New York, NY.
 
11:50 am
PVSS Award Reports
 
12:30
PVSS Lunch (on your own)
​Noon - 5:00 pm General Surgery Resident/Medical Student Scholarship Program – Open and Endovascular Training - Room 2014/16
(see Fellow/Resident/Student Program for more details) (scholarship recipients only) 
1:30 pm - 5:00 pm​

V2: Peripheral Vascular Surgery Society Paper Session II - Room 3022/24

At the end of this session, participants should be able to: 
  1. Examine the outcomes of pediatric surgical revascularization in upper and lower extremities as well as in congenital vascular conditions.
  2. Discuss recent studies describing national epidemiologic and analytic details surrounding hospital readmission following vascular surgery.
  3. Report recent investigations into surgical education and cost-effectiveness in vascular care.
  4. Explain the effectiveness of different strategies vena cava filter retrieval.
ModeratorsMichael J. Singh MD, UPMC Heart and Vascular Institute, Pittsburgh, PA
Brian W. Nolan MD, Dartmouth Hitchcock Medical Center, Lebanon, NH
 

1:30 pm
PVSS11. Intervention, Failure Mechanism, Patency, Wound Complications and Limb Salvage in Open vs Endoscopic Greater Saphenous Vein Harvest for Lower Extremity Revascularization
Vincent J. Santo, Phong Dargon, Gregory J. Landry, Timothy K. Liem, Erica L. Mitchell, Amir F. Azarbal, Gregory L. Moneta
General Surgery, Oregon Health & Science University, Portland, OR.

1:44 pm
PVSS12. Lower and Upper Extremity Arterial Bypasses in 38 Preadolescent Children
Jonathan L. Eliason, Adam Gumushian, Dawn M. Coleman, James C. Stanley
Section of Vascular Surgery, University of Michigan, Ann Arbor, MI.

1:58 pm
PVSS13. Long- Term Outcomes after Open and Endovascular Management of the Vasculature and Arterial Patterns Seen in Patients with Marfan, Vascular Ehlers Danlos and Loeys-Dietz Syndromes
Moqueet A. Qureshi1, Roy K. Greenberg1, Zenia Martin1, Matthew J. Eagleton1, Rocio Moran2
1Cleveland Clinic - Department of Vascular Surgery, Cleveland, OH; 2Cleveland Clinic - Department of Genomic Medicine, Cleveland, OH.

2:12 pm
PVSS14. Physician and Self-Referral Patient Patterns for Thoracic Outlet Syndrome Are Excellent
Kendall Likes, Danielle Rochlin, Quinn Salditch, Thadeus Dapash, Yen Baker, Roxanne DeGuzman, Julie A. Freischlag
Johns Hopkins Medical Institutions, Baltimore, MD.

2:26 pm
PVSS15. The Association Between Erythrocyte n-3 Polyunsaturated Fatty Acids (n-3 PUFAs) Content and Inflammation in Male Patients with Peripheral Artery Disease (PAD)
Marlene Grenon1, Christopher D. Owens1, Hugh Alley1, Karen Chong1, Eric Vittinghoff1, William Harris2, Millie Hughes-Fulford1, Joseph Rapp1, Michael Conte1
1UCSF, San Francisco, CA; 2University of South Dakota, Vermillion, SD.

2:40 pm
PVSS16. Expanded Polytetrafluoroethylene (ePTFE) vs. Autologous Vein as a Conduit for Vascular Reconstruction in Modern Combat Casualty Care
J. Devin B. Watson1, Jonathan J. Morrison3, Irma L. McNamee2, Thomas W. Evans2, Todd E. Rasmussen2
1San Antonio Military Medical Center, San Antonio, TX; 2US Army Institute of Surgical Research, Fort Sam Houston, TX; 3Academic Department of Military Surgery and Trauma, Royal Centre for Defence Medicine, Birmingham, United Kingdom.

2:54 pm
PVSS17. Surgical Revision for Non-Maturing Arteriovenous Fistulas
Timothy K. Liem, Francis Hacker, Ashley A. Price, Amir F. Azarbal, Gregory J. Landry, Erica L. Mitchell, Gregory L. Moneta
Oregon Health & Science University, Portland, OR.

3:08 pm
PVSS18. Decreased Readmission Is a Phone Call Away
Heather Lee, Faisal Aziz, Judith Cook, David Han, Robert Atnip, Amy B. Reed
Heart and Vascular Institute, Penn State College of Medicine, Hershey, PA.

3:22 pm
PVSS19. Addressing the Disconnect Between Reimbursement and Patient Value in Aortic Surgery
Mandy R. Maness1, Matthew B. Burruss1, Marcus Gillikin2, Timothy W. Capps1, Jill N. Zink1, Charles S. Powell1, William M. Bogey1, Frank M. Parker1, Michael C. Stoner1
1East Carolina University, Department of Cardiovascular Sciences, Section of Vascular and Endovascular Surgery, Greenville, NC; 2East Carolina Heart Institute, Greenville, NC.

3:36 pm
PVSS20. High-Quality Outpatient Diabetic Care Improves Amputation-Free Survival after Lower Extremity Revascularization for Critical Limb Ischemia
Benjamin S. Brooke1, David H. Stone1, Brian Nolan1, Randall R. De Martino1, David C. Goodman2, Jack L. Cronenwett1, Philip P. Goodney1
1Section of Vascular Surgery, Dartmouth-Hitchcock Medical Center, Lebanon, NH; 2Dartmouth Institute for Health Policy & Clinical Practice, Lebanon, NH.

3:50 pm
PVSS21. Outcomes Following Open and Endovascular Revascularization for Chronic Mesenteric Ischemia
Gabriela Velazquez, Salvatore T. Scali, Adam Beck, Robert J. Feezor, Scott A. Berceli, Thomas Huber, Catherine K. Chang
Surgery, University of Florida, Gainesville, FL.

4:04 pm
PVSS22. Creating a Vascular Skills Examination: Three New Validated Assessment Models
Malachi G. Sheahan1, Claudie Sheahan1, Jodi Gerdes1, Jean Bismuth3, Jason Lee5, Murray Shames2, Julia Wilkinson1, John Eidt4
1Louisiana State University Health Sciences Center, Marrero, LA; 2University of South Florida, Tampa, FL; 3The Methodist Hospital, Houston, TX; 4Greenville Health System University Medical Center, Greenville, SC; 5Stanford University Medical Center, Stanford, CA.

4:18 pm
PVSS23. Influence of CTA Reconstruction Software on Anatomic Measurements and Endograft Component Selection for Abdominal Aortic Aneurysm Repair
Matthew A. Corriere, Arsalla Islam, Timothy E. Craven, Thomas Conlee, Justin Hurie, Matthew Edwards
Wake Forest University School of Medicine, North Carolina, NC.

4:32 pm
PVSS24. Factors Affecting Inferior Vena Cava Filter (IVCF) Retrieval Success
Roan J. Glocker, Zdenek Novak, Thomas C. Matthews, Mark A. Patterson, William D. Jordan, Marc A. Passman
Vascular Surgery, UAB, Birmingham, AL.

​5:00 pm - 6:30 pm

CONCURRENT BREAKOUT SESSIONS

C1: How to Recruit and Retain the Best - Room 3009

At the end of this session, participants should be able to: 
  1. Identify ways to find the best students/residents.
  2. Employ methods to work with and recruit millennials.
  3. Identify opportunities to recruit and retain women and minorities.
  4. Examine the evolution of vascular surgery practices.
Moderators: Anil P. Hingorani MD, Lutheran Medical Center, Brooklyn, NY
 John E. Rectenwald MD, University of Michigan Medical Center, Ann Arbor, MI
 Eva M. Rzucidlo MD, Dartmouth Hitchcock Medical Center, Lebanon, NH
 
5:00 pm
Finding the Best Student/Resident
Amy B. Reed MD, Penn State Heart and Vascular Institute, Hershey, PA
 
5:10 pm
Recruiting and Working with Generation Y (Millennials)
Robyn A. Macsata MD, Department of Veteran Affairs Medical Center, Washington, DC
 
5:20 pm
Retaining and Recruiting Minorities
Donna M. Mendes MD, Mendes Vein Care, New York, NY
 
5:30 pm
Retaining and Recruiting Women
Patricia Numann MD, SUNY Upstate Medical University, Syracuse, NY
 
5:40 pm
Making the Job Fit: Vascular Surgery Practice Paradigms
Vivian Gahtan MD, SUNY Upstate Medical University, Syracuse, NY
 
5:50 pm
Panel Discussion
 
C2: Current Topics in Comparative Effectiveness Research - Room 3011
 
At the end of this session, participants should be able to: 
  1. Define comparative effectiveness research and differentiate it from other types of outcomes research.
  2. Report key issues in the treatment of asymptomatic carotid artery stenosis and “no-option” critical limb ischemia.
  3. Discuss different viewpoints of the debates and synthesize an opinion on optimal strategies.
  4. Assess the possible future directions of comparative effectiveness research, including leading into cost-effectiveness research.
Moderators: Louis L. Nguyen MD MBA MPH, Brigham & Women’s Hospital / Harvard Medical School, Boston, MA
Andres Schanzer MD MPH, University of Massachusetts Medical Center, Worcester, MA
Nicholas J. Morrissey MD, New York Presbyterian Hospital / Columbia University, New York, NY
 
5:00pm
Introduction
Louis L. Nguyen MD MBA MPH, Brigham & Women’s Hospital / Harvard Medical School, Boston, MA
 
5:02pm
Defining Comparative Effectiveness Research
Misty D. Humphries MD, University of California Davis Medical Center, Sacramento, CA
 
Debate: Treatment of Asymptomatic Carotid Artery Stenosis
 
5:12pm
Introduction: What are the Treatment Options for Asymptomatic Carotid Artery Stenosis?
Nicholas J. Morrissey MD, New York Presbyterian Hospital / Columbia University, New York, NY
 
5:15pm
Medical Therapy for Treatment of Asymptomatic Carotid Artery Stenosis
Rocco G. Ciocca MD, Swedish Medical Center, Seattle, WA
 
5:25pm
Interventional Therapy for Treatment of Asymptomatic Carotid Artery Stenosis
Wei Zhou MD, Stanford University Medical Center, Stanford, CA
 
5:35pm
Rebuttal and Discussion

Debate: Treatment of “No-Option” Critical Limb Ischemia
 
5:42pm
Introduction – What Treatment is Available for Patients with “No-Option” CLI?
Andres Schanzer MD MPH, University of Massachusetts Medical Center, Worcester, MA
 
5:45pm
Amputation for the Treatment of “No-Option” CLI
Raul J. Guzman MD, Beth Israel Deaconess Medical Center, Boston MA
 
5:55pm
Frontier Therapy for the Treatment of “No-Option” CLI
Virendra I. Patel MD, Massachusetts General Hospital / Harvard Medical School, Boston, MA
 
6:05pm
Rebuttal and Discussion
 
6:12pm
Moving from Comparative Effectiveness to Cost-Effectiveness Research
Louis Nguyen MD MBA MPH, Brigham & Women's Hospital / Harvard Medical School, Boston, MA
 
6:22pm
Wrap Up and Discussion
 
C3: International Forum - Room 3008
 

At the end of this session, participants should be able to:

  1. Discuss the methodology, results and conclusions of the research presented in vascular health.
  2. Gain knowledge of new technology for diagnosis and treatment of vascular disease
Moderators: Michel S. Makaroun MD, University of Pittsburgh Medical Center, Pittsburgh, PA
Jonathan D. Beard BSc ChM, Sheffield Vascular Institute, The Northern General Hospital, Sheffield, United Kingdom
Gustav Fraedrich MD, Medical University, Innsbruck, Austria
Fausto Miranda, Jr. MD, Paulista School of Medicine, Sao Paulo, Brazil
Carlo Setacci MD, University of Siena, Siena, Italy
 
5:00 pm
IF1. Familial Abdominal Aortic Aneurysm Is Not Related to a Genetic Predisposition for Atherosclerosis
Koen M. van de Luijtgaarden1, Frederico Bastos Goncalves1, Sanne E. Hoeks2, Danielle Majoor-Krakauer3, Robert J. Stolker2, Hence J. Verhagen1, Ellen V. Rouwet1
1Erasmus University Medical Center - Department of Vascular Surgery, Rotterdam, Netherlands; 2Erasmus University Medical Center - Department of Anesthesiology, Rotterdam, Netherlands; 3Erasmus University Medical Center - Department of Clinical Genetics, Rotterdam, Netherlands.
Discussant: Ronald L. Dalman MD, Stanford University School of Medicine, Stanford, CA
 
5:10 pm
IF2. Total Homocysteine Improves Risk Stratification in Elderly Patients Undergoing Endarterectomy for Their Asymptomatic High-Grade Internal Carotid Stenosis
Nikolaus Duschek1, Thomas Waldhoer2, Fahroudin Sekic1, Samarth Ghai1, Jasmin Schiebel1, Juergen Falkensammer1, Wolfgang Huebl3, Afshin Assadian1
1Wilhelminenspital Vienna, Department of Vascular Surgery, Vienna, Austria; 2Department of Epidemiology, Center for Public Health, Medical University of Vienna, Vienna, Austria; 3Wilhelminenspital Vienna, Department of Laboratory Medicine, Vienna, Austria.
 
Discussant: Joseph H. Rapp MD, University of California San Francisco, San Francisco, CA
 
5:20 pm
IF3. Early vs. Late Experience in Fenestrated Endovascular Repair for Abdominal Aortic Aneurysm
Thorarinn Kristmundsson1, Jonathan Sobocinski2, Björn Sonesson1, Nuno Dias1, Stephan Haulon2, Timothy Resch1
1Vascular Center, Skåne University Hospital, Malmö, Sweden; 2Department of Vascular Surgery, Université Lille Nord de France, Hôpital Cardiologique, Lille, France.
 
Discussant: Gustavo Oderich MD, Mayo Clinic, Rochester, MN
 
5:30 pm
IF4. Surgical or Endovascular Options for Patients with Acute Limb Ischemia? The Hybrid Procedures May Increase Clinical Outcomes
Gianmarco de Donato, Francesco Setacci, Pasqualino Sirignano, Giuseppe Galzerano, Rosaria Massaroni, Alessandro Cappelli, Carlo Setacci
Department of Medicine, Surgery and Neuroscience, Vascular and Endovascular Surgery Unit, Siena, Italy.
 
Discussant: Frank B. Pomposelli MD, St. Elizabeth’s Medical Center, Boston, MA
 

5:40 pm
IF5. Prevalence and Predictor of In-Stent Occlusion after Endovascular Treatment with Nitinol Stents for Femoropopliteal Lesion: Insight from Retrospective Multicenter Analysis for Femoropopliteal Lesion Registry
Tomoharu Dohi1, Osamu Iida1, Yoshimitsu Soga2, Mitsuyoshi Takahara3, Masaaki Uematsu1
1Kansai Rosai Hospital, Amagasaki, Japan; 2Kokura Memorial Hospital, Kitakyusyu, Japan; 3Osaka University, Suita, Japan.

Discussant: Peter A. Schneider MD, Kaiser Permanente Medical Group, Honolulu, HI

5:50 pm
IF6. 18 F-FDG-PET CT Scan – Future Gold Standard in Diagnosis of Vascular Graft Infection?​
Raghvinder P. Gambhir, Pritee Padgaonkar, Varinder Bedi, Surinder Singh
Vascular Surgery, Army Hospital, Delhi, India.

Discussant: Peter F. Lawrence, MD, UCLA Medical Center, Los Angeles, CA

6:00 pm
IF7. One-Year Results of the Multilayer Flow Modulator Stent in the Management of Thoracoabdominal Aortic Aneurysms
Sherif Sultan1, Niamh Hynes2
1Vascular & Endovascular Surgery, Western Vascular Institute, Galway, Ireland; 2Galway Clinic, Galway, Ireland.

Discussant: Daniel G. Clair MD, Cleveland Clinic Foundation, Cleveland, OH

6:10 pm
IF8. Endovascular Treatment of Abdominal Aortic Aneurysms Should Not Be Denied to High-Surgical-Risk Patients
Celio T. Mendonca1, Claudio A. Carvalho2, Janaina Weingartner1, Alexandre Y. Shiomi2, Daniel S. Costa2, Cristiano M. Schmitt2
1Red Cross University Hospital. Positivo University, Curitiba, Brazil; 2VITA Curitiba Hospital, Curitiba, Brazil.

Discussant: William D. Jordan Jr. MD, University of Alabama at Birmingham, Birmingham, AL

6:20 pm
IF9. A New Method to Quantify Aortic Biomechanics in Vivo Using Four-Dimensional Magnetic Resonance Imaging (4D MRI): Implications for Ascending Aortic Endografts
Rachel Clough, Christian Buerger, Christoph Kolbitsch, Peter Taylor, Claudia Prieto, Tobias Schaeffter
NIHR Comprehensive Biomedical Research Centre of Guy's and St Thomas' NHS Foundation Trust and King's College London, London, United Kingdom.

Discussant: Mark F. Fillinger MD Dartmouth-Hitchcock Medical Center, Lebanon, NH

6:30 pm - 7:30 pm
International Guest Reception - Room 3010
​6:45 pm - 8:15 pm General Surgery Resident/Medical Student Program Welcome Reception Co-sponsored by the SVS Young Surgeons Committee and the Peripheral Vascular Surgery Society - San Francisco Marriott Marquis, Nob Hill A-C
(see Fellow/Resident/Student Program for more details)

Contact Us

Society for Vascular Surgery
633 North Saint Clair Street, 22nd Floor | Chicago, IL 60611
Phone: 312-334-2300 | 800-258-7188
Fax: 312-334-2320
Email: vascular@vascularsociety.org

Follow Us

YouTube

VascularWeb® is the prime source for all vascular health and disease information, and is presented by the Society for Vascular Surgery®. Its members are vascular surgeons, specialists, and vascular health professionals who are specialty-trained in all treatments for vascular disease including medical management, non-invasive procedures, and surgery.